Secondary Hypersomnia: Causes, Assessment, Treatment Evidence and Safety
A cause-led guide to excessive sleepiness related to illness, medicines or substances, with disease-specific treatment guidance and funding limits.
Evidence-graded research on sleep and insomnia — melatonin, magnesium and other sleep supplements assessed by the real strength of the primary evidence.
A cause-led guide to excessive sleepiness related to illness, medicines or substances, with disease-specific treatment guidance and funding limits.
A guide to rare childhood ROHHAD, evolving symptoms, diagnostic uncertainty, ventilation and endocrine care, with experimental-treatment and funding limits.
A guide to CCHS, automatic breathing, genetics, lifetime ventilatory support, caregiver planning and associated risks, with source funding disclosures.
How chronic curtailed sleep differs from insomnia and unexplained hypersomnia, what adequate opportunity means, and when sleepiness requires assessment.
A guide to recurring profound sleepiness, diagnostic uncertainty, conditional lithium guidance, monitoring and emergency symptoms, with funding disclosures.
A guide to oxygen versus carbon dioxide, common causes of inadequate sleep breathing, specialist support, medicine risks and source funding.
A guide to childhood apnea symptoms, testing, surgery and residual disease, PAP support, montelukast cautions and source funding.
A guide to central events during OSA treatment, monitoring versus revised support, current conditional guidance, heart-failure precautions and source funding.
A guide to awake carbon dioxide, sleep breathing, CPAP versus ventilation, weight-management context, urgent signs and disclosed source funding.
A guide to nighttime grinding, awake clenching, dental protection, TMD distinctions, supplement limitations, urgent dental signs and source funding.
Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.